Fatty Liver Disease and Weight Loss: What Every Indian Should Know

India's Hidden Liver Crisis

Non-alcoholic fatty liver disease (NAFLD) now affects an estimated 38% of the Indian population — making it more common than diabetes. Yet most people have never been screened. NAFLD develops silently, with no symptoms in early stages, and can progress to inflammation, fibrosis, cirrhosis, and even liver failure if left untreated.

Why Weight Loss Is the Best Treatment

Here's the remarkable thing about NAFLD: there is no drug specifically approved to treat it. The single most effective treatment is weight loss of 7–10% of body weight. This reduces liver fat by 40–80%, resolves inflammation, and can even reverse early fibrosis. No drug, supplement, or liver "detox" comes close.

GLP-1 Medications and Liver Health

Emerging research shows GLP-1 medications benefit liver health beyond just weight loss. Semaglutide has been shown to reduce liver inflammation (NASH) in clinical trials, leading to FDA breakthrough therapy designation for this indication. For Indian patients with both obesity and fatty liver, GLP-1 therapy addresses two conditions simultaneously.

MetaFit's Liver Health Monitoring

Every MetaFit patient gets liver function tests as part of their initial assessment. For patients with elevated liver enzymes or diagnosed NAFLD, we track liver health markers throughout the weight loss journey, ensuring that treatment is producing real metabolic improvement — not just aesthetic change.